Drugs
HALIFAX, NS: HALIFAX, NS -- (Marketwired) -- 11/12/15 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV) (OTCQX: IMMVF), a clinical-stage vaccine and immunotherapy company, to ...
SEATTLE, WA: Conference Call to Be Held Today at 4:30 pm Eastern Time ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 11/11/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today repor ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/06/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced new preclinical data demonstrating that tarloxotinib bromide*, or tarloxotinib, ...
WOBURN, MA: Will Exhibit at Booth 8 at Well Characterized Biologicals, Nov. 9-10 in Reston, VA ...
BOTHELL, WA: Company Announces Issuance of Key SMARTICLES(R) Patent in Canada ...
DUBLIN, IRELAND: Compound Designed for Targeted Activity in Gastrointestinal (GI) Tract Tissues to Optimize Efficacy and Safety Profile in Range of Inflammatory Intestinal Diseases ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 11/02/15 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight"), announced today that a dividend to Knight in ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 10/29/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced that the U.S. Food and Drug Administration ("FD ...
RICHMOND, BRITISH COLUMBIA: RICHMOND, BRITISH COLUMBIA -- (Marketwired) -- 10/29/15 -- All manufactured lots of Allerject and Allerject Jr. emergency anaphylactic allergy reaction treatments were recalled by manufacturer Sanofi ...
HALIFAX, NS: Safety Review Committee Approves Higher-Dose Cohorts, Enabling DPX-RSV to Progress to the Next Phase of Clinical Program ...
EXTON, PA: Reports Sales of $344.5 million and Adjusted Diluted EPS of $0.44 -- Raises Full-Year 2015 Adjusted Diluted EPS to Range of $1.79 to $1.84 -- Conference Call Scheduled for 9 a.m. Today ...
DUBLIN, IRELAND and CAMBRIDGE, MA: Study Being Conducted by Trek Therapeutics Following Licensing of Worldwide Rights to Drug Candidate From Theravance Biopharma ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 10/26/15 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 10/26/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today issued a statement on the Company's use of specialty phar ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/22/15 -- Two British Columbia-headquartered biotech organizations are expanding their successful collaboration to develop much needed treatments fo ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/22/15 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 10/22/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the Company will release its financial results for the third quarter 2015 on Thursday, Novembe ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 10/21/15 -- Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and comm ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/20/15 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the quarter ended September 30, 2015 after market cl ...
